A population-based analysis of the rate of cytoreductive nephrectomy for metastatic renal cell carcinoma in the United States.
Standard
A population-based analysis of the rate of cytoreductive nephrectomy for metastatic renal cell carcinoma in the United States. / Jeldres, Claudio; Baillargeon-Gagne, Sara; Liberman, Daniel; Isbarn, Hendrik; Capitanio, Umberto; Shariat, Shahrokh F; Sun, Maxine; Lughezzani, Giovanni; Perrotte, Paul; Montorsi, Francesco; Graefen, Markus; Karakiewicz, Pierre I.
In: UROLOGY, 2009.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - A population-based analysis of the rate of cytoreductive nephrectomy for metastatic renal cell carcinoma in the United States.
AU - Jeldres, Claudio
AU - Baillargeon-Gagne, Sara
AU - Liberman, Daniel
AU - Isbarn, Hendrik
AU - Capitanio, Umberto
AU - Shariat, Shahrokh F
AU - Sun, Maxine
AU - Lughezzani, Giovanni
AU - Perrotte, Paul
AU - Montorsi, Francesco
AU - Graefen, Markus
AU - Karakiewicz, Pierre I
PY - 2009
Y1 - 2009
N2 - OBJECTIVE: To examine temporal, geographic, socioeconomic, and clinical determinants of cytoreductive nephrectomy (CNT) use in the surveillance, epidemiology, and end results (SEER) database, because CNT is known to improve survival in patients with metastatic renal cell carcinoma (mRCC). METHODS: Within the SEER database, we identified 6226 mRCC patients, who were either treated with CNT (n = 2038) or underwent no surgery (n = 4188) between 1989 and 2004. Chi-square and chi(2) trend tests, as well as multivariate logistic regression models, were used to assess the effect of age, gender, race, region of residence, and year of surgery on the rate of CNT. Adjustment was made for the size of the primary tumor. RESULTS: The overall rate of CNT was 30.5%. The rate of CNT increased in the most recent year quartile (P
AB - OBJECTIVE: To examine temporal, geographic, socioeconomic, and clinical determinants of cytoreductive nephrectomy (CNT) use in the surveillance, epidemiology, and end results (SEER) database, because CNT is known to improve survival in patients with metastatic renal cell carcinoma (mRCC). METHODS: Within the SEER database, we identified 6226 mRCC patients, who were either treated with CNT (n = 2038) or underwent no surgery (n = 4188) between 1989 and 2004. Chi-square and chi(2) trend tests, as well as multivariate logistic regression models, were used to assess the effect of age, gender, race, region of residence, and year of surgery on the rate of CNT. Adjustment was made for the size of the primary tumor. RESULTS: The overall rate of CNT was 30.5%. The rate of CNT increased in the most recent year quartile (P
M3 - SCORING: Zeitschriftenaufsatz
JO - UROLOGY
JF - UROLOGY
SN - 0090-4295
ER -